Terrance P. Coyne sold $2.7M of Royalty Pharma (RPRX)

Executed Jan 20, disclosed Jan 23, 3 days later, against a two-business-day limit.

Value, as filed

$2.7M

69,582 sh across 2 lots

Executed

Jan 20

the trade date, as filed

Disclosed

Jan 23

3 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Terrance P. Coyne EVP & CFO profile →

Terrance P. Coyne (EVP & CFO) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales, 1 filed past the two-business-day deadline), most often in Royalty Pharma plc (RPRX). The largest single filing was $10.3M of RPRX (242,454 sh across 5 lots, as filed), executed Feb 2.

The name

RPRX

Royalty Pharma plc RPRX · Healthcare · 36 filings in 24 months ticker →

Healthcare · Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the U…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Terrance P. Coyne in RPRX

RPRXSALE Royalty Pharma plc $646K
11,002 sh across 2 lots
Exec Aug 13
Filed Aug 17 · 5:01 PM ET RPRXSALE Royalty Pharma plc $3.5M
64,399 sh × $53.98
Exec May 26
Filed May 28 · 5:30 PM ET RPRXSALE Royalty Pharma plc $1.6M
32,916 sh × $49.78
Exec Apr 28
Filed Apr 30 · 5:30 PM ET RPRXSALE Royalty Pharma plc $1.6M
32,916 sh × $48.33
Exec Apr 1
Filed Apr 2 · 5:30 PM ET RPRXSALE Royalty Pharma plc $1.5M
32,916 sh × $45.53
Exec Mar 23
Filed Mar 25 · 5:30 PM ET RPRXSALE Royalty Pharma plc $1.5M
32,916 sh across 2 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET RPRXSALE Royalty Pharma plc $1.5M
32,916 sh × $45.32
Exec Feb 23
Filed Feb 25 · 5:30 PM ET RPRXSALE Royalty Pharma plc $10.3M
242,454 sh across 5 lots
Exec Feb 2
Filed Feb 4 · 5:30 PM ET